ConvaTec Group PLC
Research ConvaTec Group PLC (2CV) on Bullrun: market cap EUR 4.74B, P/E 49.2, dividend yield 1.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2CV
- ExchangeF
- CountryUnited Kingdom
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Market capEUR 4.74B
- P/E49.2
- Dividend yield1.9%
- Financial periodFY2025
- RevenueUSD 2.44B
- Revenue growth6.6%
- Net incomeUSD 175.00M
- Free cash flowUSD 285.00M
- Gross margin56.2%
Valuation Snapshot
latest market cap is EUR 4.74B; P/E is 49.2; dividend yield is 1.9%.
Peer valuation comparison
Latest P/E is 49.2x versus a Healthcare sector median of 23.49x (109.4% above).
Latest dividend yield is 1.88% versus a Healthcare sector median of 2.03% (7.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.44B | USD 175.00M | USD 285.00M | 56.2% | 0.09 | USD 68.00M | USD 1.52B | USD 1.52B |
| FY2024 | USD 2.29B | USD 191.00M | USD 275.00M | 56.1% | 0.09 | USD 65.00M | USD 1.20B | USD 1.69B |
| FY2023 | USD 2.14B | USD 130.30M | USD 238.20M | 56.0% | 0.06 | USD 97.60M | USD 1.31B | USD 1.69B |
| FY2022 | USD 2.07B | USD 62.90M | USD 137.50M | 53.3% | 0.03 | USD 143.80M | USD 1.30B | USD 1.61B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-26 | EUR 4.74B | 49.2 | 2.6% | 0.06 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.06 EUR, yield 1.9%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.06 USD |
| FY2024 | 0.06 USD |
| FY2023 | 0.06 USD |
| FY2022 | 0.05 USD |
| FY2021 | 0.05 USD |
About ConvaTec Group PLC
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is ConvaTec Group PLC's market cap?
ConvaTec Group PLC's market capitalization is EUR 4.74B.
What is ConvaTec Group PLC's P/E ratio?
ConvaTec Group PLC's price-to-earnings (P/E) ratio is 49.2.
Does ConvaTec Group PLC pay a dividend?
ConvaTec Group PLC has a dividend yield of 1.9%.
What does ConvaTec Group PLC do?
Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.